National Cancer Genetics MDT
The National Cancer Genetics MDT is a collaboration between UK CGG and the CanGene-CanVar Programme which aims to create a regular national forum to discuss challenging concepts and cases, with a view to improving and standardising care of patients with or at risk of inherited cancer predispositions across the UK.
Aims
The aims of the National Cancer Genetics MDT include:
-
Create a national multidisciplinary network and provide a regular forum to discuss complex cases.
-
Improve outcome and consistency of care for patients through multidisciplinary discussion with other expert colleagues.
-
Identify areas in which national guidelines are required or in need of updating.
-
Improve education and training in clinical cancer genetics.
-
Facilitate relevant publications arising from MDT content.
Hosts
Each centre in the UK will have an opportunity to lead a session, with an opportunity to host either a session of mixed interesting/unsolved cases or a themed session.
The next meeting will be 15 September 2022, 12:30pm - 1:45pm. The team in the Regional Genetics Service, Belfast Health and Social Care Trust, will be leading, with the theme "Cancer genetics- ethical dilemmas that bridge lab and clinical teams".
If you have any cases to present, please send the details to UKCGGNationalMDT@icr.ac.uk and we will forward to the coordinating team.
Previous and future meeting dates, host centres and themes are outlined here below:
|
Dates 2022 |
Centre |
Theme |
Expert Speaker |
|
Jan 20th |
NorthWest Thames |
Colorectal |
Kevin Monahan |
|
March 31st |
Cambridge |
CanRisk/PRS |
Antonis Antoniou |
|
May 19th |
Guys |
Mixed cases |
- |
|
July 21st |
GOSH |
Paediatric Cancer |
Dr Jack Bartram |
|
Sep 15th |
Belfast |
Cancer genetics- ethical dilemmas that bridge lab and clinical teams |
|
|
Nov 17th |
Edinburgh |
TBD |
|
|
Dates 2023 |
Centre |
Theme |
|
|
Jan 19th |
Wales |
TBD |
|
|
March 16th (provisional) |
Bristol |
TBD |
|
|
May 18th |
Royal Marsden NHS FT |
Sarcoma |
TBD |
|
July 20th |
Birmingham |
TBD |
|
|
Sep 21st |
Nottingham |
TBD |
|
|
Nov 16th |
Exeter |
TBD |
|
|
Dates 2024 |
Centre |
Theme |
|
|
Jan 18th |
Dundee |
TBD |
|
|
March 14th |
Oxford |
TBD |
|
|
May 16th |
Sheffield |
TBD |
|
|
July 18th |
Liverpool |
TBD |
|
|
Sep 19th |
Glasgow |
TBD |
|
|
Nov 21st |
Newcastle |
TBD |
|
|
Dates 2025 |
Centre |
Theme |
|
|
Jan 16th |
Aberdeen |
TBD |
|
|
March 20th |
Southampton |
TBD |
|
|
May 15th |
Leicester |
TBD |
|
|
July 17th |
Leeds |
TBD |
|
|
Sep 18th |
St Georges |
TBD |
|
|
Nov 20th |
Manchester |
TBD |
|
Registration
In order to protect patient confidentiality and maintain clinical governance, only approved and registered individuals working within the NHS in the area of cancer genetics are permitted to attend the meeting. You no longer need to register for each MDT. You should have received a link to download a calendar invitation for all upcoming meetings within your registration confirmation email. If you have not received this, please let us know and we can send this to you directly.
We look forward to hearing from you and to seeing you online at the meeting.
Recordings
Summaries of previous meetings and recordings of those sessions not involving sensitive patient information are available here.
